109 related articles for article (PubMed ID: 15512788)
1. Gene combination transfer to block autoimmune damage in transplanted islets of Langerhans.
Bertera S; Alexander AM; Crawford ML; Papworth G; Watkins SC; Robbins PD; Trucco M
Exp Diabesity Res; 2004; 5(3):201-10. PubMed ID: 15512788
[TBL] [Abstract][Full Text] [Related]
2. Liposome-mediated transfer of IL-1 receptor antagonist gene to dispersed islet cells does not prevent recurrence of disease in syngeneically transplanted NOD mice.
Saldeen J; Sandler S; Bendtzen K; Welsh N
Cytokine; 2000 Apr; 12(4):405-8. PubMed ID: 10805224
[TBL] [Abstract][Full Text] [Related]
3. Impact of donor immune cells in pancreatic islet transplantation.
Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
[TBL] [Abstract][Full Text] [Related]
4. Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes.
Bertera S; Crawford ML; Alexander AM; Papworth GD; Watkins SC; Robbins PD; Trucco M
Diabetes; 2003 Feb; 52(2):387-93. PubMed ID: 12540612
[TBL] [Abstract][Full Text] [Related]
5. Viral IL-10-mediated immune regulation in pancreatic islet transplantation.
Carter JD; Ellett JD; Chen M; Smith KM; Fialkow LB; McDuffie MJ; Tung KS; Nadler JL; Yang Z
Mol Ther; 2005 Aug; 12(2):360-8. PubMed ID: 16043104
[TBL] [Abstract][Full Text] [Related]
6. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
[TBL] [Abstract][Full Text] [Related]
7. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
[TBL] [Abstract][Full Text] [Related]
8. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
[TBL] [Abstract][Full Text] [Related]
9. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
[TBL] [Abstract][Full Text] [Related]
10. Indoleamine 2,3-dioxygenase expression in transplanted NOD Islets prolongs graft survival after adoptive transfer of diabetogenic splenocytes.
Alexander AM; Crawford M; Bertera S; Rudert WA; Takikawa O; Robbins PD; Trucco M
Diabetes; 2002 Feb; 51(2):356-65. PubMed ID: 11812742
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo and systemic transfer of adenovirus-mediated CTLA4Ig gene combined with a short course of FK506 therapy prolongs islet graft survival.
Akamaru Y; Ito T; Uchikoshi F; Maeda A; Tori M; Kiyomoto T; Komoda H; Miao G; Matsuda H
Transpl Immunol; 2003; 11(1):91-100. PubMed ID: 12727480
[TBL] [Abstract][Full Text] [Related]
12. Immunity to islet grafts transduced with adenovirus vectors does not inhibit long-term islet function.
Cheng J; Sun J; Sung RS
Transpl Immunol; 2009 May; 21(1):33-42. PubMed ID: 19224710
[TBL] [Abstract][Full Text] [Related]
13. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
[TBL] [Abstract][Full Text] [Related]
14. Caspase-3 gene silencing for inhibiting apoptosis in insulinoma cells and human islets.
Cheng G; Zhu L; Mahato RI
Mol Pharm; 2008; 5(6):1093-102. PubMed ID: 18828606
[TBL] [Abstract][Full Text] [Related]
15. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice.
Sung HH; Juang JH; Lin YC; Kuo CH; Hung JT; Chen A; Chang DM; Chang SY; Hsieh SL; Sytwu HK
J Exp Med; 2004 Apr; 199(8):1143-51. PubMed ID: 15078896
[TBL] [Abstract][Full Text] [Related]
16. Immunoprotection and Functional Improvement of Allogeneic Islets in Diabetic Mice, Using a Stable Indoleamine 2,3-Dioxygenase Producing Scaffold.
Hosseini-Tabatabaei A; Jalili RB; Khosravi-Maharlooei M; Hartwell R; Kilani RT; Zhang Y; Ghahary A
Transplantation; 2015 Jul; 99(7):1341-8. PubMed ID: 25769070
[TBL] [Abstract][Full Text] [Related]
17. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Füchtenbusch M; Larger E; Thebault K; Boitard C
Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets.
Téllez N; Montolio M; Biarnés M; Castaño E; Soler J; Montanya E
Gene Ther; 2005 Jan; 12(2):120-8. PubMed ID: 15578044
[TBL] [Abstract][Full Text] [Related]
19. Islet expression of M3 uncovers a key role for chemokines in the development and recruitment of diabetogenic cells in NOD mice.
Martin AP; Grisotto MG; Canasto-Chibuque C; Kunkel SL; Bromberg JS; Furtado GC; Lira SA
Diabetes; 2008 Feb; 57(2):387-94. PubMed ID: 18003753
[TBL] [Abstract][Full Text] [Related]
20. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
